LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
about
An unappreciated role for RNA surveillanceTherapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammationThe TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspiratorMembrane trafficking of death receptors: implications on signallingDeath receptor-ligand systems in cancer, cell death, and inflammationImmunopathology of inflammatory bowel diseaseStudies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cellsOn death receptor 3 and its ligands…TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signallingTNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesionsMouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaBRole of TL1A and its receptor DR3 in two models of chronic murine ileitis.The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasisDR3 regulates negative selection during thymocyte developmentSignal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3.TNF alpha and the TNF receptor superfamily: structure-function relationship(s).Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.Regulation of CD40 function by its isoforms generated through alternative splicing.Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain sheddingTL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells.The TNF-family cytokine TL1A inhibits proliferation of human activated B cellsRegulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathwayIL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells.The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling.Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.Cellular FLICE-inhibitory protein: an attractive therapeutic target?Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussionThe TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.TNFSF15 Modulates Neovascularization and InflammationFas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death.Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune diseaseExpressed sequence tags (ESTs) and single nucleotide polymorphisms (SNPs): what large-scale sequencing projects can tell us about ADME.The role of TRADD in death receptor signalingThe TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases
P2860
Q21092884-70A3E5B5-6D78-43C8-9848-7E489366AAC4Q24598725-6638EC80-05FF-43BD-87EF-2B59AED78096Q26799347-53581B6F-2EC8-42F8-A539-6EB48DA74A6EQ26852802-CBBAD979-EC52-49F7-9266-E1D04930001BQ26865568-E97D39CA-714A-430C-A1BE-8CBF637BB5DBQ27027636-B1012B7D-CD12-4719-9A56-E7BEE9CE7773Q28138623-59BFE177-B3C1-4EBF-AA4F-F9F9A69E98B9Q28189886-B9316CD0-AF3D-4E63-A5FB-BA694170ABDFQ28267084-5674D2DD-104F-4AD2-B0BA-C83B4B59702CQ28267294-289E7A70-9F69-4DD7-AB9A-1464EAE0F05BQ28271369-93EED43D-2575-4734-9222-92AA5F605E61Q28505689-D43267B6-F9DE-4D38-8D1E-288930867EDFQ30440458-273D0F86-9155-465A-95A9-A510AAEA2E1DQ30463364-841655C4-2BAF-48C9-9918-21189A9C992BQ33558790-90E77E40-36C9-436D-B41D-BDC851928F09Q33782305-3D0E3FC6-8F76-4973-808D-CF4C803F8236Q33894042-3FBD76DE-C341-4E7B-86B0-76729148BA26Q33909217-23EA9B85-B607-48A7-8D6B-19931A18A020Q33948715-CCFD6A14-DD74-4D43-9523-802248CC4B48Q34101903-58C8B918-8E19-4A52-9100-110D86875678Q34195262-E4A2273B-D05C-43EF-BDE0-79CF78692886Q34551098-DEC0B945-9772-4BD8-9DD8-0E0875BA7C3AQ34658152-21D0BFC9-9750-4F21-AD86-2EA1765BA889Q34729913-99D6A047-9731-431A-920F-B356489D22CAQ34749483-D3C75F30-F76F-455C-B972-F99CDFD41668Q34756285-C5D32475-556C-4BC9-9E2A-01297324E382Q34827734-7523FB8C-C592-4D4A-8399-5BCF967AA636Q35126225-26C20002-E54B-4AB0-BE21-70FE13B06E8CQ35186676-74F7616F-14CE-49A2-AEDF-AB480810BDD0Q35480734-396C9B95-613E-4AC5-82D4-3D91D92FBE1FQ36219538-9E151059-635D-4D05-ACD5-9CEEF42AA400Q36284920-EE44F787-FBD7-4571-B3AC-94B0CE6397DBQ36285131-DEB930C1-9715-4FB5-B01F-0BAE064F35C4Q36400294-BE4A80E0-18BE-480B-B383-0EEC637CC006Q36544769-341FDBA4-CC1D-4437-922A-72EC6D7A9F4FQ36639967-640EC54A-C7AD-4994-968B-7A8291163975Q36639973-76109C28-7851-4A61-BE8E-283667DEED94Q36659874-245D3135-C330-4B49-8EE0-733196AAAD09Q36920268-FDCA0217-6EF3-4AAF-9F38-E38F653DF9F3Q37382950-C93D7906-64A4-4349-9B8B-939D7E927ACB
P2860
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@ast
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en-gb
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@nl
type
label
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@ast
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en-gb
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@nl
prefLabel
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@ast
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en-gb
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@nl
P2093
P2860
P356
P1476
LARD: a new lymphoid-specific ...... alternative pre-mRNA splicing
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.9.4615
P407
P577
1997-04-01T00:00:00Z